"Ciprofloxacin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A broad-spectrum antimicrobial carboxyfluoroquinoline.
| Descriptor ID |
D002939
|
| MeSH Number(s) |
D03.633.100.810.835.322.186
|
| Concept/Terms |
Ciprofloxacin Hydrochloride- Ciprofloxacin Hydrochloride
- Hydrochloride, Ciprofloxacin
- Ciprofloxacin Monohydrochloride Monohydrate
- Monohydrate, Ciprofloxacin Monohydrochloride
- Monohydrochloride Monohydrate, Ciprofloxacin
|
Below are MeSH descriptors whose meaning is more general than "Ciprofloxacin".
Below are MeSH descriptors whose meaning is more specific than "Ciprofloxacin".
This graph shows the total number of publications written about "Ciprofloxacin" by people in this website by year, and whether "Ciprofloxacin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 1 | 2 |
| 2010 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 12 | 17 | 29 |
| 2018 | 9 | 20 | 29 |
| 2019 | 5 | 6 | 11 |
To return to the timeline, click here.
Below are the most recent publications written about "Ciprofloxacin" by people in Profiles.
-
In vitro inhibition and molecular docking of a new ciprofloxacin-chalcone against SARS-CoV-2 main protease. Fundam Clin Pharmacol. 2022 Feb; 36(1):160-170.
-
The application of in silico experimental model in the assessment of ciprofloxacin and levofloxacin interaction with main SARS-CoV-2 targets: S-, E- and TMPRSS2 proteins, RNA-dependent RNA polymerase and papain-like protease (PLpro)-preliminary molecular docking analysis. Pharmacol Rep. 2021 Dec; 73(6):1765-1780.
-
Neuroprotective role of camphor against ciprofloxacin induced depression in rats: modulation of Nrf-2 and TLR4. Immunopharmacol Immunotoxicol. 2021 Jun; 43(3):309-318.
-
Antimicrobial properties of diethylamine NONOate, a nitric oxide donor, against Escherichia coli: a pilot study. J Antibiot (Tokyo). 2021 04; 74(4):260-265.
-
Fluoroquinolone Antibiotics Exhibit Low Antiviral Activity against SARS-CoV-2 and MERS-CoV. Viruses. 2020 12 23; 13(1).
-
Ciprofloxacin and moxifloxacin could interact with SARS-CoV-2 protease: preliminary in silico analysis. Pharmacol Rep. 2020 Dec; 72(6):1553-1561.
-
Antimicrobial susceptibilities of the ertapenem-non-susceptible non-carbapenemase-producing Enterobacterales isolates causing intra-abdominal infections in the Asia-Pacific region during 2008-2014: Results from the Study for Monitoring the Antimicrobial Resistance Trends (SMART). J Glob Antimicrob Resist. 2020 06; 21:91-98.
-
Co-circulation of Multidrug-resistant Shigella Among Men Who Have Sex With Men in Australia. Clin Infect Dis. 2019 10 15; 69(9):1535-1544.
-
Improved determination of Neisseria gonorrhoeae gyrase A genotype results in clinical specimens. J Antimicrob Chemother. 2019 10 01; 74(10):2913-2915.
-
The Association of Antibiotic Stewardship With Fluoroquinolone Prescribing in Michigan Hospitals: A Multi-hospital Cohort Study. Clin Infect Dis. 2019 09 27; 69(8):1269-1277.